Evidence map›Paper›PMID 36792598›Full record

ArticleNature communications2023

Personalized recurrence risk assessment following the birth of a child with a pathogenic de novo mutation.

Marie Bernkopf, Ummi B Abdullah, Stephen J Bush, Katherine A Wood, Sahar Ghaffari, Eleni Giannoulatou, Nils Koelling, Geoffrey J Maher, Loïc M Thibaut, Jonathan Williams and 35 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Impact of a Genetic Diagnosis for a Child's Autism on Parental Perceptions.Journal of autism and developmental disorders · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. [Sperm Mosaic Variants and Their Influence on the Offspring].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

45 authors at 18 institutions in 3 countries.

Marie Bernkopf *Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-6650-4592
Ummi B Abdullah *Clinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Stephen J BushClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-9341-2562
Katherine A WoodClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Sahar GhaffariClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Eleni GiannoulatouVictor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia.
Nils KoellingClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-5292-4510
Geoffrey J MaherClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Loïc M ThibautCentre for Population Genomics, Garvan Institute of Medical Research, UNSW Sydney, Sydney, NSW, Australia.ORCID 0000-0003-3813-682X
Jonathan WilliamsOxford Genetics Laboratories, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.ORCID 0000-0003-2672-2450
Edward M BlairNIHR Oxford Biomedical Research Centre, Oxford, UK.
Fiona Blanco KellyOxford Centre for Genomic Medicine, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Angela BlossOxford Centre for Genomic Medicine, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Emma Burkitt-WrightManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.
Natalie CanhamDepartment of Clinical Genetics, Liverpool Women's NHS Foundation Trust, Liverpool, UK.
Alexander T DengClinical Genetics Department, Guy's Hospital, Guy's & St Thomas' NHS Foundation Trust, London, UK.ORCID 0000-0002-8121-817X
Abhijit DixitNottingham Regional Genetics Service, City Hospital Campus, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Jacqueline EasonNottingham Regional Genetics Service, City Hospital Campus, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Frances ElmslieSouth West Thames Regional Genetics Service, St George's University Hospitals NHS Foundation Trust, London, UK.
Alice GardhamNorth West Thames Regional Genetics Service, London North West University Healthcare NHS Trust, Northwick Park Hospital, Harrow, UK.
Eleanor HayNorth East Thames Regional Genetics Service, Great Ormond Street Hospital NHS Foundation Trust, London, UK.
Muriel HolderClinical Genetics Department, Guy's Hospital, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Tessa HomfraySouth West Thames Regional Genetics Service, St George's University Hospitals NHS Foundation Trust, London, UK.
Jane A HurstNorth East Thames Regional Genetics Service, Great Ormond Street Hospital NHS Foundation Trust, London, UK.
Diana JohnsonSheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Wendy D JonesNorth East Thames Regional Genetics Service, Great Ormond Street Hospital NHS Foundation Trust, London, UK.
Usha KiniNIHR Oxford Biomedical Research Centre, Oxford, UK.
Emma KivuvaClinical Genetics, Royal Devon & Exeter Hospital (Heavitree), Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
Ajith KumarNorth East Thames Regional Genetics Service, Great Ormond Street Hospital NHS Foundation Trust, London, UK.ORCID 0000-0003-3878-2856
Melissa M LeesNorth East Thames Regional Genetics Service, Great Ormond Street Hospital NHS Foundation Trust, London, UK.
Harry G LeitchNottingham Regional Genetics Service, City Hospital Campus, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Jenny E V MortonWest Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women's and Children's Hospitals NHS Foundation Trust, Birmingham, UK.
Andrea H NémethOxford Centre for Genomic Medicine, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Shwetha RamachandrappaClinical Genetics Department, Guy's Hospital, Guy's & St Thomas' NHS Foundation Trust, London, UK.ORCID 0000-0003-2639-766X
Katherine SaundersOxford Centre for Genomic Medicine, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Deborah J ShearsOxford Centre for Genomic Medicine, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Lucy SideWessex Clinical Genetics Service, University Hospital Southampton, Princess Anne Hospital, Southampton, UK.
Miranda SplittNorthern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
Alison StewartSheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Helen StewartOxford Centre for Genomic Medicine, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Mohnish SuriNottingham Regional Genetics Service, City Hospital Campus, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Penny CloustonOxford Genetics Laboratories, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Robert W DaviesDepartment of Statistics, University of Oxford, Oxford, UK.
Andrew O M WilkieClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-2972-5481
Anne GorielyClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. anne.goriely@imm.ox.ac.uk.ORCID 0000-0001-9229-7216
University of Oxford · GBNuffield Orthopaedic Centre · GBGreat Ormond Street Hospital for Children NHS Foundation Trust · GBNottingham University Hospitals NHS Trust · GBGuy's Hospital · GBChurchill Hospital · GBSheffield Children's NHS Foundation Trust · GBSt George’s University Hospitals NHS Foundation Trust · GBBirmingham Women’s and Children’s NHS Foundation Trust · GBGarvan Institute of Medical Research · AULondon North West Healthcare NHS Trust · GBMRC Weatherall Institute of Molecular Medicine · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBPrincess Anne Hospital · GBRoyal Devon and Exeter Hospital · GBUniversity of Liverpool · GBUniversity of Manchester · GBVictor Chang Cardiac Research Institute · AU

Funding

Medical Research Council G0902418Medical Research Council MC_UP_1605/2Wellcome Trust 102731/Z/13/Z
6 · The paper itself

Abstract

Following the diagnosis of a paediatric disorder caused by an apparently de novo mutation, a recurrence risk of 1-2% is frequently quoted due to the possibility of parental germline mosaicism; but for any specific couple, this figure is usually incorrect. We present a systematic approach to providing individualized recurrence risk. By combining locus-specific sequencing of multiple tissues to detect occult mosaicism with long-read sequencing to determine the parent-of-origin of the mutation, we show that we can stratify the majority of couples into one of seven discrete categories associated with substantially different risks to future offspring. Among 58 families with a single affected offspring (representing 59 de novo mutations in 49 genes), the recurrence risk for 35 (59%) was decreased below 0.1%, but increased owing to parental mixed mosaicism for 5 (9%)-that could be quantified in semen for paternal cases (recurrence risks of 5.6-12.1%). Implementation of this strategy offers the prospect of driving a major transformation in the practice of genetic counselling.

Indexed as

FathersParturitionChildFemaleGerm CellsGerm-Line MutationHumansMaleMosaicismMutationPedigreePregnancyRisk Assessment

Identifiers

PMID36792598
PMCPMC9932158
OpenAlexW4321003401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.